Market Cap
$59.6B
NTRA
Natera, Inc.
$405.59 ▼ -0.70%
Prev close $408.47Market cap$59.6B
ConsensusStrong Buy
12-mo target$355.93 (-12.1%)
▲ Bullish
Analyst conviction 9/10
Insider Selling Cluster (2 insiders)39 New Institutional Positions11 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on NTRA right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (87%)
Inst. Holders
50 funds
Inst. Value
$26.3B
Inst. Activity
39 buys / 11 sells
Insider Activity
$0.00 buy / $45.3M sell
Insider Net $
-$45.3M
Social Sentiment
50° Neutral
SEC Reports
20
Price chart 30d +24.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 28, 2026 short_volume
Short Volume: NTRA — 56.3% short (0.5M / 1.0M)
Short: 544,747 | Exempt: 2,544 | TRF Vol: 967,963 | Short Ratio: 56.3% | Off-exchange volume (dark p
Sep 23, 2026 Insider
Sheena Jonathan sold 400 shares
Director @ $385.10 ($154.0K)
Sep 23, 2026 Insider
Sheena Jonathan sold 2,175 shares
Director @ $386.71 ($841.1K)
Sep 23, 2026 Insider
Sep 4, 2026 SEC Sheena Jonathan sold 2,734 shares
Director @ $387.65 ($1.1M)
Two top executives at Natera — CEO Steven Chapman and President of Clinical Diagnostics Solomon Moshkevich — sold a comb
CLUSTER — Impact 3/10
Seven Natera insiders, including the Executive Chairman, CEO, CFO, and two Presidents, sold a total of $5.15M in shares
CLUSTER — Impact 4/10
Seven Natera insiders, including the CEO, CFO, Executive Chairman, and President of Clinical Diagnostics, sold a total o
CLUSTER — Impact 3/10
Jun 30, 2026 Inst.
FMR LLC — DOUBLED
5,451,396 shares ($1.5B)
Analyst ratings buy % -2.2%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
87% rate it Buy or better · 30 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 1, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Sep 25, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Sep 9, 2026 | UBS | MAINTAIN | Buy | 55% |
| Sep 8, 2026 | Rothschild & Co | INITIATE | Buy | 58% |
| Aug 13, 2026 | Citigroup | MAINTAIN | Buy | 55% |
| Aug 12, 2026 | Piper Sandler | MAINTAIN | Overweight | 54% |
| Aug 12, 2026 | Stephens & Co. | MAINTAIN | Overweight | 54% |
| Aug 12, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Aug 7, 2026 | TD Cowen | MAINTAIN | Buy | 56% |
| Aug 7, 2026 | Citigroup | MAINTAIN | Buy | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 12 | 14 | 4 | 0 | 0 | 87% | |
| Aug 1, 2026 | 12 | 14 | 4 | 0 | 0 | 87% | |
| Jul 1, 2026 | 12 | 14 | 4 | 0 | 0 | 87% | |
| Jun 1, 2026 | 11 | 13 | 3 | 0 | 0 | 89% | |
| May 1, 2026 | 11 | 14 | 3 | 0 | 0 | 89% | |
| Apr 1, 2026 | 10 | 15 | 3 | 0 | 0 | 89% | |
| Mar 1, 2026 | 10 | 15 | 3 | 0 | 0 | 89% | |
| Feb 1, 2026 | 9 | 15 | 3 | 0 | 0 | 89% |
Price targets
Where 22 covering analysts think NTRA trades over the next 12 months.
$355.93 -12.1% upside Sell
Current$404.99 Low$280.00 Median$360.00 High$460.00 22 analysts
$280.00$460.00
Analyst rating Strong Buy· 1.4/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 0 bullish, 2 bearish, 0 mixed, 18 neutral · avg impact 2.5/10.
NEUTRALCLUSTER3/10
Two top executives at Natera — CEO Steven Chapman and President of Clinical Diagnostics Solomon Mosh
Sep 4, 2026
BEARISHCLUSTER4/10
Seven Natera insiders, including the Executive Chairman, CEO, CFO, and two Presidents, sold a total
Aug 29, 2026
NEUTRALCLUSTER3/10
Seven Natera insiders, including the CEO, CFO, Executive Chairman, and President of Clinical Diagnos
Aug 15, 2026
NEUTRALCLUSTER2/10
A cluster of 7 Natera insiders, including the Executive Chairman, CEO, CFO, and President of Clinica
Aug 8, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 28, 2026
short_volume
Short Volume: NTRA — 56.3% short (0.5M / 1.0M)
Short: 544,747 | Exempt: 2,544 | TRF Vol: 967,963 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)
Sep 16, 2026
short_volume
Short Volume: NTRA — 57.4% short (0.3M / 0.6M)
Short: 316,078 | Exempt: 468 | TRF Vol: 550,518 | Short Ratio: 57.4% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: NTRA — 76.0% short (0.7M / 1.0M)
Short: 726,805 | Exempt: 1,722 | TRF Vol: 956,753 | Short Ratio: 76.0% | Off-exchange volume (dark pool + OTC)
Sep 7, 2026
dark_pool
Dark Pool: NTRA — 1.1M shares, 33,262 trades
Week starting 2026-09-07. Total ATS volume: 1,091,199 shares across 33,262 trades.
Aug 31, 2026
dark_pool
Dark Pool: NTRA — 1.4M shares, 42,457 trades
Week starting 2026-08-31. Total ATS volume: 1,428,756 shares across 42,457 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.24 | $-0.61–$0.13 | 62.8% | +2.4% | 11↑ 1↓ | $0.7B | 15 |
| Next Q | $-0.07 | $-0.34–$0.31 | -119.1% | -0.4% | 12↑ 0↓ | $0.7B | 14 |
| Current FY | $-1.39 | $-2.02–$-0.63 | 8.7% | +0.5% | 13↑ 1↓ | $2.9B | 16 |
| Next FY | $-0.10 | $-1.93–$1.74 | 92.5% | -16.8% | 9↑ 4↓ | $3.5B | 16 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.238 | — |
| 7d ago | $-0.238 | — |
| 30d ago | $-0.244 | +0.006 |
| 60d ago | $-0.378 | +0.140 |
| 90d ago | $-0.364 | +0.126 |
Institutional ownership
Which big funds own NTRA (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $26.3B total value (96,968,217 shares) as of 2026-Q2. Top holders: JPMORGAN, BlackRock,, VANGUARD. Net buying activity: 39 institutions added/increased vs 11 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 12,865,346 | $3.5B | 13.3% | — |
| BlackRock, Inc. | 10,914,608 | $3.0B | 11.3% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,228,216 | $1.7B | 6.4% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,782,640 | $1.6B | 6.0% | — |
| FMR LLC | 5,451,396 | $1.5B | 5.6% | DOUBLED +113.4% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,040,738 | $1.1B | 4.2% | — |
| STATE STREET CORP | 3,655,618 | $992.3M | 3.8% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 2,750,013 | $744.6M | 2.8% | — |
| FRANKLIN RESOURCES INC | 2,725,903 | $739.9M | 2.8% | — |
| Castle Hook Partners LP | 2,596,276 | $704.8M | 2.7% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| FMR LLC | DOUBLED | 2,554,254 | 5,451,396 | +113.4% | $1.5B |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | TRIM | 3,207,366 | 2,218,366 | -30.8% | $602.2M |
| NORGES BANK | NEW | — | 1,828,122 | — | $496.2M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 767,231 | 1,720,152 | +124.2% | $466.9M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 1,191,732 | 1,503,706 | +26.2% | $408.2M |
| D. E. Shaw & Co., Inc. | DOUBLED | 491,336 | 1,279,255 | +160.4% | $347.3M |
| JANE STREET GROUP, LLC | DOUBLED | 263,677 | 926,986 | +251.6% | $251.6M |
| WORLDQUANT MILLENNIUM ADVISORS LLC | ADD | 356,459 | 591,460 | +65.9% | $160.6M |
| UBS Group AG | ADD | 422,899 | 553,739 | +30.9% | $150.3M |
| Man Group plc | ADD | 265,440 | 406,753 | +53.2% | $110.4M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
3 insiders, 50 transactions. Net -$45.3M — $0.00 bought, $45.3M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 400 | $385.10 | $154.0K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 2,175 | $386.71 | $841.1K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 2,734 | $387.65 | $1.1M |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 1,293 | $388.71 | $502.6K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 2,320 | $389.69 | $904.1K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 110 | $390.42 | $42.9K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 390 | $385.29 | $150.3K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 2,300 | $386.64 | $889.3K |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 2,846 | $387.74 | $1.1M |
| Sep 23, 2026 | Sheena Jonathan | Director | SELL | 1,341 | $388.76 | $521.3K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NTRA.
Shares short
4,797,175
Settlement Sep 15, 2026
Change vs prior
-13.0%
Semi-monthly cycle
Days to cover
4.7
At avg daily volume
Of shares outstanding
≈3.3%
Estimate — not % of float
All NTRA filing & press-release reports (35)
- CLUSTER reportSep 4, 2026
- CLUSTER reportAug 29, 2026
- CLUSTER reportAug 15, 2026
- CLUSTER reportAug 8, 2026
- CLUSTER reportAug 6, 2026
- CLUSTER reportJul 30, 2026
- CLUSTER reportJul 18, 2026
- CLUSTER reportJul 16, 2026
- CLUSTER reportJul 9, 2026
- CLUSTER reportJul 7, 2026
- CLUSTER reportJul 1, 2026
- CLUSTER reportJun 27, 2026
- 144 reportJun 25, 2026
- CLUSTER reportJun 23, 2026
- CLUSTER reportJun 18, 2026
- CLUSTER reportJun 17, 2026
- CLUSTER reportJun 10, 2026
- 3 reportJun 9, 2026
- CLUSTER reportJun 6, 2026
- CLUSTER reportJun 4, 2026
- CLUSTER reportJun 3, 2026
- CLUSTER reportMay 29, 2026
- CLUSTER reportMay 16, 2026
- CLUSTER reportMay 7, 2026
- CLUSTER reportMay 6, 2026
- CLUSTER reportApr 30, 2026
- CLUSTER reportApr 9, 2026
- CLUSTER reportApr 4, 2026
- CLUSTER reportMar 21, 2026
- CLUSTER reportMar 18, 2026
- CLUSTER reportMar 17, 2026
- CLUSTER reportMar 12, 2026
- CLUSTER reportMar 12, 2026
- CLUSTER reportMar 4, 2026
- INST-CLUSTER reportFeb 28, 2026